• PP 2 (AG 1879): Applied Src Kinase Inhibition in Research

  2026-06-11

  PP 2 (AG 1879) empowers researchers with nanomolar-precision inhibition of Src family kinases, enabling robust dissection of cancer, immune, and vascular signaling pathways. This guide translates recent breakthroughs—like the role of Src kinases in ROS-mediated vascular contraction—into actionable protocols, troubleshooting strategies, and advanced use-cases, maximizing the impact of your experimental workflows.

• Jasplakinolide in High-Resolution Actin Cytoskeleton Mapping

  2026-06-11

  Explore how Jasplakinolide, a potent actin polymerization inducer, is revolutionizing cell biology by enabling high-resolution mapping of the actin cytoskeleton. Discover unique assay strategies, scientific insights, and practical guidance for advanced research applications.

• Oral Gepotidacin for Gonorrhoea: Phase 3 Efficacy and Implic

  2026-06-10

  The EAGLE-1 phase 3 trial demonstrated that oral gepotidacin is non-inferior to standard ceftriaxone plus azithromycin therapy for uncomplicated urogenital gonorrhoea, providing the first robust evidence for an effective oral alternative. These findings represent a significant advance in addressing antibiotic resistance and treatment accessibility in Neisseria gonorrhoeae infections.

• (-)-Blebbistatin: Precision Tools for Translational Cytoskel

  2026-06-10

  Explore how (-)-Blebbistatin is reshaping translational research by enabling precise, reversible inhibition of non-muscle myosin II. This article provides mechanistic insights, strategic workflow guidance, and a critical appraisal of the evolving landscape at the intersection of cytoskeletal biology, cardiac optogenetics, and next-generation mechanobiology—demonstrating why APExBIO’s (-)-Blebbistatin stands as a benchmark compound beyond conventional product summaries.

• Tofacitinib Citrate (CP-690550): Precision in Immune Regulat

  2026-06-09

  Tofacitinib citrate (CP-690550 citrate) stands out as a selective JAK3 inhibitor for dissecting immune signaling pathways and modeling inflammatory disorders. This article delivers advanced, workflow-focused guidance for leveraging Tofacitinib citrate in translational research, with troubleshooting insights grounded in the latest vascular inflammation findings.

• Semi-Automated Screening of Fast-Dissociating Antibodies for

  2026-06-09

  Miyoshi et al. introduce a semi-automated single-molecule microscopy platform to identify highly specific, fast-dissociating monoclonal antibodies directly from hybridoma cultures. Their findings enable rapid discovery of antibody probes ideal for multiplex super-resolution imaging, with implications for advancing protein tagging and detection methods in cell biology.

• Applied Workflows with (-)-Norepinephrine (+)-bitartrate

  2026-06-08

  (-)-Norepinephrine (+)-bitartrate from APExBIO offers precision control for modeling adrenergic receptor signaling and cardiovascular pathophysiology. This guide delivers actionable protocols, troubleshooting insights, and strategic context to optimize reproducibility in cardiomyopathy research.

• Prostaglandin E2: Mechanistic Depth and Cross-System Insight

  2026-06-08

  Explore the molecular mechanisms and cross-system impact of Prostaglandin E2 (PGE2) in inflammation, cardiovascular health, and translational research. This in-depth article unveils new comparative perspectives and practical assay guidance for researchers.

• Patient-Derived Gastric Cancer Assembloids Enhance Preclinic

  2026-06-07

  This study introduces a methodology for generating gastric cancer assembloids by integrating patient-matched tumor organoids with diverse stromal cell subpopulations. The resulting models more accurately recapitulate tumor microenvironment complexity, enabling improved drug response prediction and investigation of resistance mechanisms.

• Flavopiridol (L868275): Advanced CDK Inhibition in Cancer Re

  2026-06-06

  Flavopiridol (L868275) delivers pan-CDK inhibition, enabling robust cell cycle arrest and apoptosis protocols in cancer research and stem cell assays. This article translates the latest mechanistic insights and reference-backed workflows into actionable guidance, unlocking superior reproducibility and experimental control.

• S-Adenosylhomocysteine: Unraveling Its Role in Methylation a

  2026-06-05

  Explore the pivotal role of S-Adenosylhomocysteine in methylation cycle regulation and neural differentiation, with advanced insights into assay optimization and mechanistic implications for research. This article offers a distinct perspective, integrating recent findings and practical guidance.

• ER Stress and Prometastatic States Induced by Apoptosis in T

  2026-06-05

  Conod et al. (2022) demonstrate that tumor cells surviving near-lethal apoptosis acquire stable prometastatic states through ER stress, cellular reprogramming, and a cytokine storm. This discovery redefines the origin of metastasis and identifies cell-death-induced reprogramming as a critical therapeutic target for cancer research.

• Arrb2 in Hepatocytes Drives M2 Polarization to Mitigate Hepa

  2026-06-04

  This study uncovers the mechanistic role of hepatocyte-specific Arrb2 in promoting M2 macrophage polarization and alleviating hepatic ischemia–reperfusion injury (IRI) via upregulation of the metabolite 6-ketoLCA. The findings highlight a novel communication axis between hepatocytes and macrophages that may inform new experimental models and therapeutic strategies for liver transplantation research.

• Tolazoline: α2-Adrenergic Receptor Antagonist in Airway and

  2026-06-04

  Tolazoline’s dual mechanism as an α2-adrenergic receptor antagonist and moderate ATP-sensitive potassium channel blocker unlocks detailed interrogation of airway cholinergic signaling and islet insulin modulation. Explore evidence-based protocols, troubleshooting strategies, and actionable insights that set Tolazoline apart for in vitro and translational research.

• Neuroligin 1 Loss in D2-MSNs Drives Repetitive Behaviors in

  2026-06-03

  This study establishes a direct mechanistic link between Neuroligin 1 deficiency in striatal D2 receptor-expressing medium spiny neurons and the emergence of autistic-like repetitive behaviors, mediated by PKC overactivation and neuronal hyperexcitability. The findings clarify key cell-type-specific circuit mechanisms underlying restricted and repetitive behaviors and point toward new intervention strategies for autism spectrum disorder.

421 records 13/29 page Previous Next First page 上5页 1112131415 下5页 Last page